Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: Q4QD99
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 165 | 169 | PF00656 | 0.508 |
CLV_C14_Caspase3-7 | 191 | 195 | PF00656 | 0.463 |
CLV_NRD_NRD_1 | 107 | 109 | PF00675 | 0.696 |
CLV_NRD_NRD_1 | 247 | 249 | PF00675 | 0.619 |
CLV_NRD_NRD_1 | 305 | 307 | PF00675 | 0.534 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.734 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.606 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.493 |
CLV_PCSK_FUR_1 | 56 | 60 | PF00082 | 0.689 |
CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.706 |
CLV_PCSK_KEX2_1 | 299 | 301 | PF00082 | 0.603 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.589 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.740 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.611 |
CLV_PCSK_PC1ET2_1 | 299 | 301 | PF00082 | 0.644 |
CLV_PCSK_PC1ET2_1 | 58 | 60 | PF00082 | 0.597 |
CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.659 |
CLV_PCSK_PC7_1 | 74 | 80 | PF00082 | 0.627 |
CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.602 |
DEG_APCC_DBOX_1 | 247 | 255 | PF00400 | 0.522 |
DEG_SCF_FBW7_1 | 324 | 330 | PF00400 | 0.535 |
DEG_SPOP_SBC_1 | 362 | 366 | PF00917 | 0.619 |
DOC_CKS1_1 | 274 | 279 | PF01111 | 0.635 |
DOC_CKS1_1 | 324 | 329 | PF01111 | 0.528 |
DOC_MAPK_gen_1 | 53 | 63 | PF00069 | 0.568 |
DOC_USP7_MATH_1 | 308 | 312 | PF00917 | 0.533 |
DOC_USP7_MATH_1 | 313 | 317 | PF00917 | 0.492 |
DOC_USP7_MATH_1 | 362 | 366 | PF00917 | 0.769 |
DOC_WW_Pin1_4 | 273 | 278 | PF00397 | 0.607 |
DOC_WW_Pin1_4 | 323 | 328 | PF00397 | 0.609 |
DOC_WW_Pin1_4 | 358 | 363 | PF00397 | 0.827 |
LIG_14-3-3_CanoR_1 | 118 | 124 | PF00244 | 0.545 |
LIG_14-3-3_CanoR_1 | 265 | 274 | PF00244 | 0.664 |
LIG_14-3-3_CanoR_1 | 312 | 320 | PF00244 | 0.398 |
LIG_BRCT_BRCA1_1 | 195 | 199 | PF00533 | 0.622 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.597 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.626 |
LIG_FHA_1 | 261 | 267 | PF00498 | 0.672 |
LIG_FHA_2 | 161 | 167 | PF00498 | 0.625 |
LIG_FHA_2 | 226 | 232 | PF00498 | 0.643 |
LIG_LIR_Apic_2 | 272 | 277 | PF02991 | 0.685 |
LIG_SH2_CRK | 274 | 278 | PF00017 | 0.688 |
LIG_SH2_GRB2like | 135 | 138 | PF00017 | 0.624 |
LIG_SH2_SRC | 192 | 195 | PF00017 | 0.470 |
LIG_SH2_STAP1 | 262 | 266 | PF00017 | 0.541 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.456 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.701 |
LIG_SH3_3 | 221 | 227 | PF00018 | 0.552 |
LIG_SH3_3 | 350 | 356 | PF00018 | 0.625 |
LIG_TRAF2_1 | 120 | 123 | PF00917 | 0.701 |
LIG_TRAF2_1 | 143 | 146 | PF00917 | 0.738 |
LIG_TRAF2_1 | 163 | 166 | PF00917 | 0.616 |
LIG_TRAF2_1 | 228 | 231 | PF00917 | 0.596 |
LIG_TRAF2_1 | 233 | 236 | PF00917 | 0.517 |
LIG_TRAF2_1 | 331 | 334 | PF00917 | 0.750 |
LIG_TRAF2_1 | 65 | 68 | PF00917 | 0.667 |
MOD_CK1_1 | 354 | 360 | PF00069 | 0.780 |
MOD_CK1_1 | 361 | 367 | PF00069 | 0.751 |
MOD_CK2_1 | 117 | 123 | PF00069 | 0.717 |
MOD_CK2_1 | 140 | 146 | PF00069 | 0.778 |
MOD_CK2_1 | 160 | 166 | PF00069 | 0.683 |
MOD_CK2_1 | 207 | 213 | PF00069 | 0.554 |
MOD_CK2_1 | 225 | 231 | PF00069 | 0.568 |
MOD_CK2_1 | 332 | 338 | PF00069 | 0.768 |
MOD_GlcNHglycan | 119 | 122 | PF01048 | 0.750 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.767 |
MOD_GlcNHglycan | 150 | 156 | PF01048 | 0.730 |
MOD_GlcNHglycan | 168 | 171 | PF01048 | 0.681 |
MOD_GlcNHglycan | 184 | 187 | PF01048 | 0.636 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.639 |
MOD_GlcNHglycan | 267 | 270 | PF01048 | 0.550 |
MOD_GlcNHglycan | 287 | 291 | PF01048 | 0.508 |
MOD_GlcNHglycan | 315 | 318 | PF01048 | 0.513 |
MOD_GlcNHglycan | 366 | 369 | PF01048 | 0.799 |
MOD_GSK3_1 | 136 | 143 | PF00069 | 0.772 |
MOD_GSK3_1 | 193 | 200 | PF00069 | 0.521 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.458 |
MOD_GSK3_1 | 323 | 330 | PF00069 | 0.614 |
MOD_GSK3_1 | 354 | 361 | PF00069 | 0.790 |
MOD_N-GLC_1 | 136 | 141 | PF02516 | 0.625 |
MOD_N-GLC_1 | 207 | 212 | PF02516 | 0.590 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.590 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.380 |
MOD_NEK2_1 | 219 | 224 | PF00069 | 0.669 |
MOD_NEK2_1 | 301 | 306 | PF00069 | 0.620 |
MOD_PIKK_1 | 123 | 129 | PF00454 | 0.589 |
MOD_PIKK_1 | 160 | 166 | PF00454 | 0.726 |
MOD_PIKK_1 | 351 | 357 | PF00454 | 0.626 |
MOD_PKA_2 | 117 | 123 | PF00069 | 0.736 |
MOD_PKA_2 | 243 | 249 | PF00069 | 0.506 |
MOD_Plk_1 | 230 | 236 | PF00069 | 0.589 |
MOD_Plk_1 | 286 | 292 | PF00069 | 0.591 |
MOD_Plk_2-3 | 140 | 146 | PF00069 | 0.778 |
MOD_Plk_2-3 | 230 | 236 | PF00069 | 0.659 |
MOD_Plk_4 | 153 | 159 | PF00069 | 0.719 |
MOD_Plk_4 | 188 | 194 | PF00069 | 0.462 |
MOD_ProDKin_1 | 273 | 279 | PF00069 | 0.603 |
MOD_ProDKin_1 | 323 | 329 | PF00069 | 0.620 |
MOD_ProDKin_1 | 358 | 364 | PF00069 | 0.825 |
MOD_SUMO_for_1 | 202 | 205 | PF00179 | 0.621 |
MOD_SUMO_rev_2 | 296 | 301 | PF00179 | 0.637 |
TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.729 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.654 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.751 |
TRG_ER_diArg_1 | 78 | 80 | PF00400 | 0.740 |
TRG_NES_CRM1_1 | 52 | 67 | PF08389 | 0.666 |
TRG_Pf-PMV_PEXEL_1 | 108 | 113 | PF00026 | 0.703 |
TRG_Pf-PMV_PEXEL_1 | 255 | 259 | PF00026 | 0.601 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0P630 | Trypanosomatidae | 31% | 100% |
A0A3Q8IBB1 | Leishmania donovani | 86% | 99% |
A4HYD4 | Leishmania infantum | 86% | 99% |
D0A0R5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9AS67 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 100% |
V5AZ24 | Trypanosoma cruzi | 34% | 100% |